about
Cyclin-dependent kinase inhibitor 1A (P21)Bone morphogenetic protein 7Bone morphogenetic protein 4Ataxin 1Cyclin dependent kinase inhibitor 2AGrowth factor receptor bound protein 10Signal transducing adaptor family member 1Cyclin dependent kinase inhibitor 2DInhibin subunit beta AAnkyrin repeat and LEM domain containing 2Sirtuin 1Cyclin dependent kinase inhibitor 2BCyclin dependent kinase inhibitor 2CPRKR interacting protein 1Inhibin subunit alphaRas homolog family member HDynein light chain LC8-type 1PRKR interacting protein 1 (IL11 inducible), isoform CRA_aAlpha 2-HS glycoproteinCyclin-dependent kinase inhibitor 1BCyclin-dependent kinase inhibitor 1C (P57)Cyclin dependent kinase inhibitor 2BCyclin dependent kinase inhibitor 2CCyclin dependent kinase inhibitor 2DSirtuin 1Tumor suppressor ARFBaculoviral IAP repeat-containing 3Ankyrin repeat and LEM domain containing 2Ataxin 7Dynein light chain LC8-type 1Prkr interacting protein 1 (IL11 inducible)Ras homolog family member HSignal transducing adaptor family member 1Circadian clock protein KaiB Pro_1424Circadian clock protein KaiB tlr0482Gpb1p YOR371CSerine/threonine/tyrosine protein kinase RAD53 YPL153CDynein light chain LC8-type 1Ankyrin repeat and LEM domain containing 2Cyclin-dependent kinase inhibitor 2C
P682
Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicitySIRT1 regulates the function of the Nijmegen breakage syndrome proteinp15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
P921
Q14902457-C2967F6A-65CC-4450-8EB1-4E7528423AACQ14903113-EF1EC5EA-1307-432C-BF16-5DE5498607E8Q14903410-7CD38500-06D6-4EC5-BCFE-118E438C27F5Q14905517-81A0BA3C-6DEF-4198-B6C2-F1FDE8CACA63Q14907028-478688BB-EE77-4555-9D9A-DE8790253C45Q14914349-67501163-806D-40AF-91F1-23FBDEF82C35Q21097366-973D8387-1747-45DC-B5D4-D5016C8BD15BQ21105502-0D826389-B633-44E0-80F9-15F1803E34E7Q21107468-6A31A757-AE26-4B99-BB75-FA6F0F6F56FEQ21109436-34E835E8-2011-4E91-A78F-FDADF752CAC7Q21109436-BE03B4D0-FC54-4904-A7D7-4503E462B93DQ21113719-A8B34AEF-B5DC-4E4B-9C6F-B684B9C5F2D5Q21114046-C581B26A-492A-4477-BC97-942D6FC5DA85Q21114047-18B2C042-EC90-41BF-B294-4C588C5D5A5AQ21114148-5A6281AA-67A1-4E67-92D6-68111F330FB8Q21114698-F1BE2795-6F9F-4B0E-842F-963B0143004CQ21127035-94A1F47D-4690-49E7-AFC9-4FE08BD52B8FQ21132100-D6D95CDA-D909-4C11-981A-8C5B7075AB51Q21150347-79CDE4CF-CA40-40A0-8EAA-9D8D7476E29CQ21154397-3F33F8F4-815F-4645-9CB4-66F0A81B286DQ21495041-16357E91-4854-4ABB-8D57-7FC9A3B0A497Q21495041-395632A2-6C83-4B06-8FCA-8341E720609AQ21495042-47C309F8-92B7-4325-B1BB-6C6DDDA97EC9Q21495042-B2C04F28-C4BA-4D35-BD49-37B5B2C6F4FCQ21495043-428ED352-1732-430B-85D2-A13464554EEDQ21495047-9CB756E2-B66B-40C3-949F-7723DB9FDB68Q21495048-D24E1B01-0D7A-4BDA-822C-E86F72385E7FQ21498104-57A79143-B73E-4D5E-A8E9-151BCADB79BAQ21499012-E1E1394C-F1F2-42D3-8948-6885A997A4E1Q21499188-392C8272-5BAE-48A4-AE73-89D3291A273DQ21981192-449F290C-6426-454E-B7F3-EC69CAF2D112Q21984107-93900D62-F847-4FEE-9AC0-F485C55EFBABQ21984798-9A1322BA-20D2-43E8-8B92-27EF8C7C768FQ21984798-EEC0EE17-ECE5-4F3F-B971-078549F58AD6Q21987900-56138B7E-C388-4C2E-8C93-D1B25565E4DBQ21987977-6FAC4815-D68C-4601-930C-DC64F06E6535Q21991498-FAE0DB29-B311-466F-AF54-3E2D60140E6AQ23475970-29D59022-4E5E-4565-8B03-713F9BEBC316Q23611938-E18A423F-334A-44B0-90DB-34A6AD8B5D0DQ27549434-7A0F0AC4-25F4-4A3B-B126-0C9B90B6F6EB
P682
description
Any process that stops, preven ...... hosphate groups to a molecule.
@en
biologisch proces
@nl
name
negative regulation of phosphorylation
@en
type
label
negative regulation of phosphorylation
@en
altLabel
GO:0042326
@en
down regulation of phosphorylation
@en
down-regulation of phosphorylation
@en
downregulation of phosphorylation
@en
prefLabel
negative regulation of phosphorylation
@en
P128
P2888
P686
GO:0042326